000 04502cam a2200385Ii 4500
001 95098
003 ES-MaUEC
005 20230102112647.0
006 m o d
007 cr cnu|||unuuu
008 161228s2017 sz o 001 0 eng d
020 _a3319460382
_q(electronic bk.)
020 _a9783319460383
_q(electronic bk.)
020 _z3319460366
020 _z9783319460369
_q(print)
035 _a(OCoLC)967282904
_z(OCoLC)967370930
_z(OCoLC)974650596
_z(OCoLC)980997599
_z(OCoLC)1005773441
_z(OCoLC)1011849147
040 _aN$T
_cN$T
_dIDEBK
_dGW5XE
_dYDX
_dN$T
_dAZU
_dUAB
_dCOO
_dOCLCO
_dUPM
_dOCLCO
_dOCLCF
_dIOG
_dVT2
_dOCLCO
_dMERER
_dESU
_dJBG
_dIAD
_dICW
_dICN
_dOCLCQ
_dOCLCO
_dOTZ
_dOCLCQ
_dOCLCO
_dOCLCA
_dU3W
_dOCLCO
_dES-MaUEC
_bspa
050 4 _aRC280.E55
_b2017 EB
245 0 0 _aDiagnostic and therapeutic nuclear medicine for neuroendocrine tumors
_cKarel Pacak, David Taïeb, editors.
264 1 _aCham, Switzerland
_bHumana Press
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 0 _aContemporary endocrinology
505 0 _aClassification of neuroendocrine tumors -- Molecular genetics of Pheochromocytoma and paraganglioma -- Molecular Genetics of MEN1-related Neuroendocrine Tumors -- Molecular genetics of MEN2-related neuroendocrine tumors -- Molecular genetics of Neuroblastoma -- Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors -- Current and future radiopharmaceuticals in neuroendocrine tumors imaging -- SPECT/CT, PET/CT and PET/MR: Principles -- Internal dosimetry: Principles and Applications to NET -- Principles and Application of Molecular Imaging for Personalised Medicine and Guiding Interventions in Neuroendocrine Tumors -- Tumor metabolism and metabolomics of pheochromocytomas and paragangliomas -- Radionuclide imaging of pheochromocytoma and paraganglioma in the era of multi-omics -- Radionuclide imaging of Head and neck PGLs -- Radionuclide imaging of Chromaffin cell tumors -- Radionuclide imaging of Gastrointestinal neuroendocrine tumors -- Radionuclide imaging of Pancreatic neuroendocrine tumors -- Radionuclide imaging of Pulmonary, thymic neuroendocrine tumors and other neuroendocrine tumors -- Radionuclide imaging of Medullary thyroid carcinoma -- 131I-MIBG therapy for pheochromocytoma/paraganglioma and neuroblastoma -- Somatostatin receptors-based radionuclide therapy -- Alpha radionuclide therapy: Principles and Applications to NET -- Nanoparticles for Radionuclide Imaging and Therapy: Principles.
520 3 _aBased on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles. Comprehensive and up-to-date, Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors will assist and guide physicians who encounter patients with these conditions, either from a diagnostic or therapeutic standpoint, and particularly emphasizes the current and emerging medical devices and imaging and therapeutic options.
650 7 _aMedicina nuclear
_2embne
_0(OCoLC)fst01040348
_0
_9138396
700 1 _aPacak, Karel,
_eeditor literario
700 1 _aTaïeb, David,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-46038-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95098
_d95098
_x1